The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Popovsky Mark A since 2005.
The trader's CIK number is 1325505.
At the time of the last reporting, Popovsky Mark A was the VP, Corporate Medica of Haemonetics Corp. (stock ticker symbol HAE).
Also see all insider trading activities at Haemonetics Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | HAE | 246 | $10,910 | 10,000 | $619,800 | 10,000 | $288,820 |
| 2007 | HAE | 535 | $21,181 | 24,000 | $1,183,402 | 24,000 | $545,232 |
| 2006 | HAE | 486 | $19,549 | 7,000 | $351,400 | 7,000 | $159,033 |
| 2005 | HAE | 441 | $11,995 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-05-01 | HAE | Buy | 246 | 44.35 | 10,910 |
| 2008-01-02 | HAE | Option Ex | 10,000 | 28.88 | 288,820 |
| 2008-01-02 | HAE | Sale | 10,000 | 61.98 | 619,800 |
| 2007-11-01 | HAE | Buy | 253 | 40.66 | 10,287 |
| 2007-07-02 | HAE | Option Ex | 7,000 | 22.72 | 159,026 |
| 2007-07-02 | HAE | Sale | 7,000 | 52.79 | 369,502 |
| 2007-05-01 | HAE | Buy | 282 | 38.63 | 10,894 |
| 2007-04-25 | HAE | Option Ex | 7,000 | 22.72 | 159,026 |
| 2007-04-25 | HAE | Sale | 7,000 | 48.00 | 336,000 |
| 2007-02-02 | HAE | Option Ex | 10,000 | 22.72 | 227,180 |
| 2007-02-02 | HAE | Sale | 10,000 | 47.79 | 477,900 |
| 2006-11-01 | HAE | Buy | 228 | 38.76 | 8,837 |
| 2006-05-01 | HAE | Buy | 258 | 41.52 | 10,712 |
| 2006-02-02 | HAE | Option Ex | 7,000 | 22.72 | 159,033 |
| 2006-02-02 | HAE | Sale | 7,000 | 50.20 | 351,400 |
| 2005-05-02 | HAE | Buy | 441 | 27.20 | 11,995 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Popovsky Mark A (VP, Corporate Medica of Haemonetics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.